New MBC Treatments: Triple-Negative; HER2+; and ER+, HER2- New MBC Treatments: Triple-Negative; HER2+; and ER+, HER2-

The latest therapeutic options improve progression-free survival for some patients.Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news